Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis.
Targeted epithelial tight junction dysfunction causes immune activation and contributes to development of experimental colitis.
复制标题
DOI:
10.1053/j.gastro.2008.10.081
复制
发表时间:
2009-02
期刊:
影响因子:
29.4
通讯作者:
Turner JR
中科院分区:
文献类型:
--
作者:
Su L;Shen L;Clayburgh DR;Nalle SC;Sullivan EA;Meddings JB;Abraham C;Turner JR
Inflammatory bowel disease (IBD) is a multifactorial disease thought to be caused by alterations in epithelial function, innate and adaptive immunity, and luminal microbiota. The specific role of epithelial barrier function remains undefined, although increased activity of intestinal epithelial myosin light chain kinase (MLCK), which is the primary mechanism of tumor necrosis factor (TNF)-induced barrier dysfunction, occurs in human IBD. We aimed to determine whether in an intact epithelium, primary dysregulation of the intestinal epithelial barrier by pathophysiologically relevant mechanisms can contribute to development of colitis. We developed transgenic (Tg) mice that express constitutively-active MLCK (CA-MLCK) specifically within intestinal epithelia. Their physiology, immune status, and susceptibility to disease were assessed and compared to non-Tg littermate controls. CA-MLCK Tg mice demonstrated significant barrier loss, but grew and gained weight normally and did not develop spontaneous disease. CA-MLCK Tg mice did, however, develop mucosal immune activation demonstrated by increased numbers of lamina propria CD4+ lymphocytes, redistribution of CD11c+ cells, increased production of interferon (IFN)-γ and TNF, as well as increased expression of epithelial MHC class I. When challenged with CD4+CD45+ Rbhi lymphocytes, Tg mice developed an accelerated and more severe form of colitis and had shorter survival times than non-Tg littermates. Primary pathophysiologically relevant intestinal epithelial barrier dysfunction is insufficient to cause experimental intestinal disease but can broadly activate mucosal immune responses and accelerate the onset and severity of immune-mediated colitis.
登录
查看更多内容
DOI:
10.1084/jem.20050407
发表时间:
2006-03-20
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
Olson TS;Reuter BK;Scott KG;Morris MA;Wang XM;Hancock LN;Burcin TL;Cohn SM;Ernst PB;Cominelli F;Meddings JB;Ley K;Pizarro TT
通讯作者:
Pizarro TT
DOI:
10.1111/j.1440-1746.2008.05325.x
发表时间:
2008-05-01
影响因子:
4.1
作者:
Pulimood, Anna B.;Ramakrishna, Balakrishna S.;Balasubramanian, Kunnissery A.
通讯作者:
Balasubramanian, Kunnissery A.
影响因子:
29.4
作者:
KATZ, KD;HOLLANDER, D;ROTTER, JI
通讯作者:
ROTTER, JI
DOI:
10.1083/jcb.129.2.489
发表时间:
1995-04
期刊:
The Journal of cell biology
影响因子:
--
作者:
Hermiston ML;Gordon JI
通讯作者:
Gordon JI
影响因子:
4.4
作者:
Marski, M;Kandula, S;Abraham, C
通讯作者:
Abraham, C